Showing results (1-10 of 6) with videos related to
Sort By:
Pageof 1
Der Nervenarzt|August 4, 2019
[Aspects of nutrition for prevention and treatment of chronic neurological diseases]Verena Isabell LeussinkCNS Drugs|July 12, 2018
Restoring Axonal Function with 4-Aminopyridine: Clinical Efficacy in Multiple Sclerosis and BeyondVerena Isabell Leussink, Xavier Montalban, Hans-Peter HartungJournal of the Peripheral Nervous System : JPNS|March 13, 2016
Fampridine-PR (prolonged released 4-aminopyridine) is not effective in patients with inflammatory demyelination of the peripheral nervous systemVerena-Isabell Leussink, Mark Stettner, Clemens Warnke, et al.Current Opinion in Neurology|April 13, 2011
Risks and benefits of multiple sclerosis therapies: need for continual assessment?Bernd C Kieseier, Heinz Wiendl, Hans-Peter Hartung, et al.Brain and Behavior|June 6, 2024
Addition of quantitative MRI to the routine clinical care of patients with multiple sclerosis-Results from the MAGNON projectVerena Isabell Leussink, Manda Jankovic, Marie Groth, et al.Therapeutic Advances in Neurological Disorders|September 14, 2012
Symptomatic therapy in multiple sclerosis: the role of cannabinoids in treating spasticityVerena Isabell Leussink, Leila Husseini, Clemens Warnke, et al.Pageof 1